By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Lancet 



     
Phone: Fax:


SEARCH JOBS








Company News
The Lancet Publishes Phase ll Results From Shire (SHPG)'s Investigational Anti-MAdCAM Antibody Showing Significantly Increased Remission Rates In Patients With Moderate-To-Severe Ulcerative Colitis 5/18/2017 7:44:57 AM
Celltrion Healthcare (068270.KQ): Lancet Publishes Full Data-Set From Influential NOR-SWITCH Study 5/12/2017 6:48:52 AM
Summit Therapeutics: Phase II CoDIFy Trial Results Published In Lancet Infectious Diseases 5/2/2017 10:58:54 AM
Phase II CoDIFy Trial Results Published In Lancet Infectious Diseases With Data Showing Summit Therapeutics’s Ridinilazole Achieved Statistical Superiority Over Vancomycin In The Treatment Of C. Difficile Infection 5/1/2017 11:56:07 AM
Positive Results Of Phase IIb Clinical Trial Of Pharmalink AB's Nefecon In Primary IgA Nephropathy Published In The Lancet 3/29/2017 7:37:37 AM
International Myeloma Foundation Release: Landmark Study Published Today In The Lancet Shows Clear Myeloma Survival Benefit With Triple Drug Combination 12/27/2016 6:27:39 AM
Galapagos (GLPG.BR) Release: The Lancet Publishes FITZROY Study Results With Filgotinib In Crohn's 12/15/2016 10:21:25 AM
Amgen (AMGN) And Cytokinetics (CYTK) Release: The Lancet Publishes Results From COSMIC-HF Trial Showing Omecamtiv Mecarbil Significantly Improved Cardiac Function In Patients With Chronic Heart Failure 12/1/2016 7:10:42 AM
UCB, Inc. (UCBJF.PK) Release: The Lancet Publishes First Head-To-Head Study Of CIMZIA (Certolizumab Pegol) And Humira (Adalimumab) In Bio-Naïve Rheumatoid Arthritis Patients 11/15/2016 10:22:38 AM
Interleukin Genetics (ILGN) Cites Role in Key Antisense Drug Trial Published In The Lancet 9/22/2016 8:49:28 AM
12345678910...
//-->